metaPreg - Cloxazolam / Oxazolam during pregnancy

Cloxazolam / Oxazolam updated on 02-10-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Growth parameters and prematurity
Preterm (< 37 weeks)	1.16 [1.07, 1.26]	-	1 study	267,218	7,557	not evaluable	ROB	1.59 [1.34; .]
Small for gestational age (weight)	1.11 [1.03, 1.19]	-	1 study	265,788	7,555	not evaluable	ROB	1.46 [1.22; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	1.54 [1.27, 1.86]	-	1 study			not evaluable	ROB	2.45 [1.86; .]
1 non statistically significant endpoints reported in only one study